Early Detection of Metabolic Syndrome and Obesity Comorbidities

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

275 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-03-31

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess :

Compare predictive value of waist to-height ratio and bio-electrical impedance analysis versus BMI in early detection of metabolic syndrome parameters and complication of obesity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Predicting Obesity Consequences Using Body Measure and Urine Metabolomics

NCT04989062

Non-Alcoholic Fatty Liver Disease Body Composition Electric Impedance

UNKNOWN

Anthropometric Assessment of Abdominal Obesity and Health Risk in Children and Adolescents

NCT01595100

Obesity

COMPLETED

The Association Between Abdominal Obesity, Gluteal Muscles Strength and Endurance in Young and Middle-aged Adults.

NCT07022691

Abdominal Obesity in Young and Middle Aged Adults Gluteal Muscles Strength and Endurance

ACTIVE_NOT_RECRUITING

Pediatric Metabolic Syndrome Study

NCT03570840

Metabolic Syndrome Overweight and Obesity Cardiovascular Risk Factor

COMPLETED

Correlation of Irisin and Adipokine Levels With Body Mass Index and Risk Factors for Metabolic Syndrome in Hispanic Children

NCT02320110

Overweight Obesity Thinness

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Childhood Obesity is defined as a body mass index (BMI) above the 95th percentile for sex and age.It is Labelled as a national epidemic and affects one in three adults and one in six children in the United States of America.Worldwide several countries have witnessed a double or triple escalation in the prevalence of obesity in the last three decades probably due to urbanization, sedentary lifestyle, and increase consumption of high-Calorie processed food.Based upon the World Population Review 2020, Egypt ranked as the highest 19th country in the world and the 7th highest country in the Arab region, with a 32% obesity rate. In Qena government study was conducted on 1000 students were chosen randomly from all grades of primary schools the overall prevalence of obesity and Overweight was 13.9% and 16.2% respectively. Girls were more obese than boys.

The alarming increase in childhood obesity foreshows a tremendous burden of chronic disease prevention in the future public healthcare systems worldwide. Obesity prevention is a critical factor in controlling Obesity-related Non-communicable diseases (OR-NCDs), including insulin resistance/ metabolic syndrome, coronary artery Disease ,cancer and psychological problems.

Metabolic syndrome is a clustering of abdominal obesity-associated factors including elevated waist Circumference(WC), elevated blood pressure (BP), elevated glucose, elevated triglycerides (TGs) or reduced high-Density lipoprotein cholesterol (HDL-C).two key components of metabolic syndrome glucose and triglycerides are overproduced by the fatty liver. So liver is therefore a key determinant of metabolic abnormalities and prevalence of both metabolic syndrome and Non-alcoholic fatty liver (NAFLD) increases with obesity.

There are various diagnostic methods for metabolic syndrome in children and adolescents. Based on the world Health organization(WHO) criteria it diagnosed when three or more of the following features are found: body Mass index (BMI):\>95th percentile, hyperinsulinemia or impaired fasting glucose or impaired glucose tolerance, BP\>95th percentile, triglycerides (TG)\>105/136 mg/dL (1.2/1.5 mmol/L) for children aged\<10 and\>10 years Respectively ,high density lipoprotein (HDL)-C\<35 mg/dL (0.9 mmol/L).

While BMI is a simple measure calculated by dividing the body weight by the squared height, it does not fully Reflect adiposity or body composition. So a better anthropometric measures than BMI to screen for central obesity are needed. . Among the anthropometric measures used to evaluate adiposity, the waist circumference and waist-To-height ratio (WHtR) can be easily measured in clinical settings and can act as an indicator of central obesity and cardio metabolic risk.

In this study we will Compare predictive value of waist to-height ratio and bio-electrical impedance analysis versus BMI in early detection of metabolic syndrome.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Disorders in Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Waist-height ratio

Waist-height ratio as early predictors of metabolic syndrome in primary school obese children

Intervention Type DIAGNOSTIC_TEST

body mass index

Body mass index as early predictors of metabolic syndrome in primary school obese children

Intervention Type DIAGNOSTIC_TEST

Bio-electrical impedance analysis

Bio-electrical impedance analysis as early predictors of metabolic syndrome in primary school obese children

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Obese children (Body mass index \>95th percentile) aged 6-12 years old

Exclusion Criteria

Patient who aged \<6 or\>12 years Presence of chronic illness (diabetes, asthma, endocrine disease) Presence of obesity as a part of genetic syndrome Presence of history of long term drug intake (corticosteroids )

Minimum Eligible Age

6 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No